openPR Logo
Press release

Next Generation Sequencing – a powerful tool for collecting genetic data!

08-05-2021 09:54 AM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

The next-generation sequencing effort currently being executed across numerous research laboratories focuses on whole-genome sequencing with applications in diagnosing disease and assisting in treatments. Next-generation sequencing produces high-quality, sensitive, archival-accurate results in a timely manner thus enabling the researchers to conduct and compare genetic analysis. Mapping of the genetic basis of complex traits such as eye and lung disease, metabolic syndrome, and complex diseases like Alzheimer's and Huntington's disease will greatly benefit from next-generation sequencing.

Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/158

Some of the most exciting developments in next generation sequencing technology are Affinity+ and eRAXnext genomics systems that use Affinity chemistry to sequentially register and tag DNA fragments for automated tracking and analysis. Additionally, they use Affinity chemistry with Ingenuity Smart probes for multiplexed DNA analysis and tracking.

The growing need for early detection of cancer and infectious diseases is propelling growth of the next-generation sequencing market. According to the World Health Organization, approximately 13% of cancers diagnosed in 2018 globally were attributed to carcinogenic infections, including Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus, hepatitis C virus, and Epstein-Barr virus. According to The Burden of Cancer Worldwide, in 2018, there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. Moreover, the growing demand for DNA testing due to rapid advancements in whole-genome and exome sequencing procedures is further expected to augment the growth of the next-generation sequencing market.

In February 2021, QIAGEN and INOVIO Pharmaceuticals announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO's therapies

In August 2020, Ancestry launches a next-generation sequencing product. The new product aims to help customers gain insights into their health and risk factors.

Download PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/158

Major Market Competitors: Thermo Fisher Scientific Inc., Agilent Technologies, Inc., BioMerieux S.A., F. Hoffmann-La Roche Ltd, Qiagen N.V., Illumina, Inc., Oxford Nanopore Technologies, and Beijing Genomics Co. Ltd.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

𝗔𝗯𝗼𝘂𝘁 𝗖𝗼𝗵𝗲𝗿𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:-
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Sequencing – a powerful tool for collecting genetic data! here

News-ID: 2347179 • Views: 237

More Releases from Coherent Market Insights (CMI)

Hyperbaric Oxygen Therapy (HBOT) Devices Market 2021-2028 | Fink Engineering Pty …
Growing prevalence of diabetic foot ulcers is expected to grow the need for hyperbaric oxygen therapy devices, which is expected to boost the global hyperbaric oxygen market growth during the forecast period. According to the National Center for Biotechnology Information, the prevalence of diabetic foot ulcers (DFU) among hospitalized patients in China ranged from 4% - 10% in 2015. Request Sample Report + Related Graphs & Charts @: https://www.coherentmarketinsights.com/insight/request-sample/553 Key Players in This
3D Cell Culture Market is Expected to Exhibit a CAGR of 23.4% by forecast 2021-2 …
Growing cases infectious diseases and cancer is expected to boost the global 3D cell culture market growth over the forecast period. Moreover, increasing demand for 3D cell culture for treatment of numerous diseases is expected to accelerate the market growth in the near future. According to the World Health Organization (WHO), September 2018 data finding, cancer is the second leading cause of death globally, and is responsible for an estimated
Life Sciences BPO Market 2021-2028 | Booming Globally with Catalent, Boehringer …
In life sciences, research and development BPO services include biometric, competitive intelligence pipeline research, R&D portfolio management, and more. Furthermore, drug development services include clinical data management, regulatory services, and pharmacovigiliance. The global life sciences BPO market is projected to account for US$ 667.3 Bn in terms of value by the end of 2027. Request Sample Report + Related Graphs & Charts @: https://www.coherentmarketinsights.com/insight/request-sample/24 Key Players in This Report Include Catalent, Boehringer Ingelheim
Urea Breath Test Market to Reach $157.2 Million, at 5.1% CAGR by 2028 | Mayoli S …
Urea Breath Test Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Urea Breath Test industry with an attention on the Global market. The report gives key insights available status of the Urea Breath Test producers and is an important wellspring of direction and course for organizations and people keen on the business. By and large, the report gives an inside

All 5 Releases


More Releases for Affinity

Affinity Dental Announces Addition of Dr. Harker Press Release
Affinity Dental Announces Addition of Dr. Payton Harker to Clinic’s Staff Arizona-based complete family dental care practice welcomes dental school graduate of Midwestern University; passionate professional takes pride in providing gentle care so patients experience an exceptional visit. Queen Creek, AZ – March 27, 2019 – Dr. Payton Harker, dental school graduate of Midwestern University in Glendale, Arizona, has joined the acclaimed staff of Affinity Dental, a Queen Creek-based complete
Affinity Publisher beta launched – try it free
The Affinity range of professional creative software takes a step closer to completion with the launch of desktop publishing app Affinity Publisher in a free public beta today (30 August). Anyone can download and test the pre-release version of the app from https://affinity.serif.com/publisher. Affinity Publisher is the result of thousands of hours of development time dedicated by the multi-award-winning team at developer Serif’s UK headquarters. Serif are emphasising that the app is still
Draw inspiration anywhere with Affinity Designer for iPad
Affinity Designer for iPad brings professional vector graphic design to the iPad for the first time. Developed with input from a team of leading professional graphic designers and based on Apple Design Award-winning technology, Affinity Designer is the most ambitious creative app developed for iPad. Managing Director of developer Serif, Ashley Hewson, says: “Affinity Designer for iPad takes all the power and precision of our desktop version and converts it into
Affinity Chromatography Reagents Market: Company Analysis And Forecast To 2024
Global Affinity Chromatography Reagents Market: Overview Affinity chromatography, also known as bioselective adsorption, is a type of liquid chromatography for purification of a specific molecule or a group of molecules from complex mixtures. The fundamental principle comprising the method is the isolation of biomolecules on the basis of a reversible interaction between a target molecule (protein) and a specific bioligand that has been immobilized on an inert matrix. Examples of these
Affinity for Consumers Towards Home Automation Market
Home automation solutions are some of the most sought-after services in the world in the consumer markets. The demand for home automation solutions is much more pronounced in the developed economies than the emerging ones, but the latter is catching up to the competition. Automation solutions are constantly evolving these days in terms of efficiency, ability, and overall performance. A lot of regions refer to home automation solutions as an
ANTARIS SOLAR selected to be NICEIC photovoltaic affinity partner
ANTARIS SOLAR, solar technology provider with headquarters in Germany, has been selected as the PV affinity partner by NICEIC. The partnership brings together German quality with the standards of UK’s leading voluntary body for electrical installation matters. Waldaschaff, Germany, 03/11/2011. After an extensive selection process NICEIC (www.niceic.com), the UK’s leading voluntary body for electrical contractors, has selected ANTARIS SOLAR (www.antaris-solar.co.uk) to be its photovoltaic affinity partner. Distribution and shipment of